THE SHARE: Change: +0.02 (+0.27%) / Price: 7.34 / Currency: SEK / 2021-04-16 17:09 (CEST)
  • Home
  • About
    • Introduction
    • Board of Directors
    • Management Team
    • Medical Advisors
  • Technology
    • EPR Effect
    • Publications
    • Patent
  • Portfolio
    • Pipeline
    • SpagoPix
    • Tumorad
  • Investor Relations
    • The Share
    • Analyst Coverage
    • Owners
    • Financial Reports
    • Corporate Governance
    • Financial Calendar
    • Shareholder’s Personal Data
    • Share Issue
  • Media
    • Presentations
    • Events
    • Image Bank
    • News
    • Press Releases
  • Contact
    • Contact us
    • Career

  • 26 Mar, 2021
    Spago Nanomedical enters Nasdaq First North Growth Market – BioStock
Back

About Spago Nanomedical

Spago Nanomedical AB is a Swedish nanomedicines company in clinical development phase. The company´s development projects are based on a platform of polymeric materials with unique properties for more precise diagnosis and treatment of solid tumors.

Address

Spago Nanomedical AB
Scheelevägen 22
SE-223 63 Lund
Sweden

Contact

Phone: +46 46 811 88
LinkedIn

Member of:

Copyright © 2021 Spago Nanomedical AB. All Rights Reserved.
Design by Clavis Communications